There is little to no market for these, and I highly doubt they will make it to market in the first place. And remember this still has to A: get a patent, something it should have already did, and B: get approved by the FDA. Something I really am not expecting to happen. For me, there are way too many warning signs here, from the CEO, the the drug it self, to the way this company has been run, to the fact that they have never got a drug approved etc. Could they hit a home run and have everything fall in place, sure, but it's not likely at all, and I really don't expect this and I have a strong feeling the CEO is thinking the same thing.